The Truth, The Whole Truth, Nothing But the Truth: No Lie MRI

“It is always the best policy to speak the truth – unless, of course, you are an exceptionally good liar,” so spoke the English author Jerome K. Jerome. This, of course, was back in the days when being an ‘exceptionally good liar’ was enough. From individuals to corporations to governments, trust...

AdvaMed 2008 Now Accepting Panel Proposal Applications

Our friends at AdvaMed are gearing up for their annual medical technology conference and exhibition to be held September 21-24, 2008 in Washington, D.C. In 2007, the event attracted more than 1,100 senior level executives representing some 500 companies from 35 states and 25 countries. AdvaMed members...

SignaLife Seeks Solace in Signalcare

Leveraging the experience gained and relationships developed through the deployment of its Fidelity 100 Heart Monitor, SignaLife, a Greenville, SC firm specializing in biomedical signal monitoring, has established Singalcare, a division focused on developing, acquiring and testing therapies capable of...

DelSite to Test Needle-Free Bird Flu Vaccine

DelSite Biotechnologies, a wholly owned subsidiary of Carrington Laboratories, received a shipment of clinical-grade bird flu antigen and will commence production of a nasal powder bird flu vaccine. The vaccine is scheduled to enter a Phase I human clinical trial later this year. Avian Flu is one of many...

Walgreens’ Marketing Engine to Drive Ready Response

The irreverent use of the phrase made famous by LifeAlert – I’ve fallen and I can’t get up – was a fixture of my childhood. Though the ad seems dated, LifeAlert’s emergency care technology is virtually identical to what it was in the eighties. LifeAlert has partnered with the...

Find and Treat Coronary Artery Disease with Bayer’s Medrad-Possis Posse

Bayer Healthcare affiliate Medrad and Minneapolis, MN-based Possis Medical have entered into a definitive merger agreement whereby Medrad will acquire Possis for $19.50 a share, or $361 million. The merger will capitalize on each company’s strengths to create a synergistic cardiovascular portfolio and...

Allied HealthCare Reports Bleak Outlook

It’s rare to see a company come clean with the brutal accord found in Allied HealthCare Products’ recent press releases. The company disclosed Friday that its second quarter net income fell almost 98%. The sharp decline resulted from gross margins that fell by about $960,000 compared to last year. Low...

Biolase Turnaround Continues; New Indications for Dental Laser

Jake St. Philip, Chief Executive Officer of Biolase, continues to instill investor confidence as he draws the company out of an abysmal year. Biolase, which traded over $10/share as late as April, hit a 52-week low of $2.20 in December. Shares opened at $3.47 today. A downturn in domestic and international...